Join to View Full Profile
315 Trent DrDurham, NC 27705
Phone+1 919-286-0411
Dr. Yarrington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Yarrington is an infectious disease specialist in Durham, NC. He received his medical degree from McGaw Medical Center of Northwestern University and has been in practice 2 years. He is experienced in epidemiology, health technology/informatics, and antibiotic stewardship.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 2017 - 2020
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2014 - 2017- Northwestern University The Feinberg School of MedicineClass of 2014
Certifications & Licensure
NC State Medical License 2017 - 2025
IL State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
American Board of Preventive Medicine Clinical Informatics
Publications & Presentations
PubMed
- Cardiac Kaposi Sarcoma Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome: A Case Report.Anna-Maria B Dagher, Jeffrey Lee, Hayley E Cunningham, Julian J Weiss, Michael E Yarrington
Cureus. 2025-01-01 - Risk Factors for Invasive Surgical Site Infections Among Adult Single Liver Transplant Recipients at Duke University Hospital in the Period 2015-2020.Manuela Carugati, Sana Arif, Michael E Yarrington, Lindsay Y King, Matt Harris
Transplantation Direct. 2024-12-01 - 1 citationsBeyond Infection: Mortality and End-of-Life Care Associated With Infectious Disease Consultation in an Academic Health System.Alison G C Smith, Michael E Yarrington, Arthur W Baker, Gary M Cox, Kristen V Dicks
Clinical Infectious Diseases. 2024-10-15
Press Mentions
Fluoroquinolone Use Decreases Following FDA Black Box WarningSeptember 11th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
